TENOFOVIR DISOPROXIL/EMTRICITABINE/EFAVIRENZ Viatris 300/200/600 tenofovir disoproxil maleate 300mg/emtricitabine 200mg/efavirenz 600mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

tenofovir disoproxil/emtricitabine/efavirenz viatris 300/200/600 tenofovir disoproxil maleate 300mg/emtricitabine 200mg/efavirenz 600mg tablet bottle

alphapharm pty ltd - emtricitabine, quantity: 200 mg; efavirenz, quantity: 600 mg; tenofovir disoproxil maleate, quantity: 300 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; sodium metabisulfite; hyprolose; colloidal anhydrous silica; croscarmellose sodium; magnesium stearate; ferric oxide; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - tenofovir disoproxil/ emtricitabine/ efavirenz mylan 300/200/600 is indicated for the treatment of hiv infected adults over the age of 18 years.,this indication is based on analyses of plasma hiv-1 rna levels and cd4 cell counts in controlled studies of viread, emtriva and stocrin in treatment-na?ve and treatment experienced adults.

Ultravist 300 New Zealand - English - Medsafe (Medicines Safety Authority)

ultravist 300

bayer new zealand limited - iopromide 623 mg/ml equivalent to iodine 300 mg/ml - solution for infusion - 300 mg/ml - active: iopromide 623 mg/ml equivalent to iodine 300 mg/ml excipient: hydrochloric acid as 10% solution sodium calcium edetate trometamol water for injection - for intravascular use and use in body cavities. contrast enhancement in computerised tomography (ct), arteriography and venography, intravenous/intra-arterial digital subtraction angiography (dsa), intravenous urography, use for ercp, arthrography and examination of other body cavities. ultravist 240: also for intrathecal use. ultravist 370: especially for angiocardiography. ultravist 300/370: not for intrathecal use.

Topiramate Actavis 200 New Zealand - English - Medsafe (Medicines Safety Authority)

topiramate actavis 200

teva pharma (new zealand) limited - topiramate 200mg;   - film coated tablet - 200 mg - active: topiramate 200mg   excipient: colloidal silicon dioxide croscarmellose sodium opadry ii pink 85g34776 magnesium stearate mannitol microcrystalline cellulose pregelatinised maize starch - topiramate actavis is indicated in adults and children. topiramate actavis tablet range is not suitable for any children weighing less than 25 kg and is not suitable as monotherapy for children or adolescents weighing less than 50 kg. - as monotherapy in patients with newly diagnosed epilepsy - for conversion to monotherapy in patients with epilepsy - as add-on therapy in partial onset seizures, generalised tonic-clonic seizures or seizures associated with lennox-gastaut syndrome.

STRIBILD tenofovir disoproxil fumarate 300mg, emtricitabine 200 mg, elvitegravir 150 mg, cobicistat 150 mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

stribild tenofovir disoproxil fumarate 300mg, emtricitabine 200 mg, elvitegravir 150 mg, cobicistat 150 mg tablet bottle

gilead sciences pty ltd - tenofovir disoproxil fumarate, quantity: 300 mg; emtricitabine, quantity: 200 mg; elvitegravir, quantity: 150 mg; cobicistat, quantity: 150 mg - tablet, film coated - excipient ingredients: hyprolose; lactose monohydrate; microcrystalline cellulose; silicon dioxide; croscarmellose sodium; magnesium stearate; sodium lauryl sulfate; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350; indigo carmine aluminium lake - stribild is indicated as a single tablet regimen for the treatment of hiv infection in treatment-na?ve adults. stribild is also indicated in certain virologically suppressed (hiv1 rna <50 copies/ml) adult patients on a stable antiretroviral regimen at start of therapy in order to replace their current antiretroviral treatment regimen (see clinical trials). patients must not have a history of treatment failure or known mutations associated with resistance to the antiretroviral components of stribild (tenofovir df, emtricitabine or elvitegravir). stribild is a fixed dose combination of one integrase inhibitor, one pharmacokinetic enhancer and two nucleos(t)ide hiv-1 reverse transcriptase inhibitors.

Tenofovir/Emtricitabine 300/200 ARX tenofovir disoproxil fumarate 300 mg emtricitabine 200 mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

tenofovir/emtricitabine 300/200 arx tenofovir disoproxil fumarate 300 mg emtricitabine 200 mg tablet bottle

arrotex pharmaceuticals pty ltd - tenofovir disoproxil fumarate, quantity: 300 mg; emtricitabine, quantity: 200 mg - tablet, film coated - excipient ingredients: lactose; magnesium stearate; colloidal anhydrous silica; crospovidone; indigo carmine aluminium lake; macrogol 8000; purified talc; titanium dioxide; polyvinyl alcohol - tenofovir/emtricitabine 300/200 arx is indicated for the treatment of hiv infected adults over the age of 18 years, in combination with other antiretroviral agents.,pre-exposure prophylaxis tenofovir/emtricitabine 300/200 arx is indicated in combination with safer sex practices for pre-exposure prophylaxis (prep) to redcue the risk of sexually acquired hiv-1 in adutls at high risk. this indication is based on clinical trials in men who have sex with men (msm) at high risk for hiv-1 infection and in heterosexual serodiscordant couples.

Tenofovir/Emtricitabine 300/200 ARX tenofovir disoproxil fumarate 300 mg emtricitabine 200 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

tenofovir/emtricitabine 300/200 arx tenofovir disoproxil fumarate 300 mg emtricitabine 200 mg tablet blister pack

arrotex pharmaceuticals pty ltd - tenofovir disoproxil fumarate, quantity: 300 mg; emtricitabine, quantity: 200 mg - tablet, film coated - excipient ingredients: titanium dioxide; colloidal anhydrous silica; crospovidone; indigo carmine aluminium lake; macrogol 8000; lactose; polyvinyl alcohol; purified talc; magnesium stearate - tenofovir/emtricitabine 300/200 arx is indicated for the treatment of hiv infected adults over the age of 18 years, in combination with other antiretroviral agents.,pre-exposure prophylaxis tenofovir/emtricitabine 300/200 arx is indicated in combination with safer sex practices for pre-exposure prophylaxis (prep) to reduce the risk of sexually acquired hiv-1 in adults at high risk. this indication is based on clinical trials in men who have sex with men (msm) at high risk for hiv-1 infection and in heterosexual serodiscordant couples.

Arrow - Ranitidine 300 New Zealand - English - Medsafe (Medicines Safety Authority)

arrow - ranitidine 300

actavis new zealand limited - ranitidine hydrochloride 336mg equivalent to ranitidine 300 mg;   - film coated tablet - 300 mg - active: ranitidine hydrochloride 336mg equivalent to ranitidine 300 mg   excipient: croscarmellose sodium magnesium stearate microcrystalline cellulose opadry white ys-22-18096 purified water

Arrow - Roxithromycin 300 New Zealand - English - Medsafe (Medicines Safety Authority)

arrow - roxithromycin 300

teva pharma (new zealand) limited - roxithromycin 300mg;   - coated tablet - 300 mg - active: roxithromycin 300mg   excipient: colloidal silicon dioxide glucose hyprolose hypromellose magnesium stearate maize starch povidone propylene glycol purified talc titanium dioxide water

Auro-Quetiapine 200 New Zealand - English - Medsafe (Medicines Safety Authority)

auro-quetiapine 200

aurobindo pharma nz limited - quetiapine fumarate 230.244mg equivalent to 200 mg quetiapine - film coated tablet - 200 mg - active: quetiapine fumarate 230.244mg equivalent to 200 mg quetiapine excipient: calcium hydrogen phosphate dihydrate colloidal silicon dioxide hypromellose lactose monohydrate macrogol 400 magnesium stearate microcrystalline cellulose opacode black s-1-17823 povidone purified talc sodium starch glycolate titanium dioxide - acute and chronic psychoses, including schizophrenia.